Release Date: 15/02/17 19:07 Summary: Notice of General Meeting/Proxy Form Price Sensitive: No Download Document 557.83KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%